v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Net revenues $ 5,168,036 $ 3,169,920
Operating expenses:    
Direct costs of revenue 2,534,213 1,903,936
Research and development 35,550 30,000
Management contingent share plan 18,878
Selling, general and administrative 2,875,124 2,764,086
Total operating expenses 5,444,887 4,716,900
Loss from operations (276,851) (1,546,980)
Change in fair value of warrant liabilities 31,594
Gain from extinguishment of Senior PIK Notes 1,863,834
Loss from legal settlement (18,250)
Interest expense (973,135) (889,792)
Other non-operating expense, net (186,950) (79,464)
Total non-operating (expense) income, net (1,178,335) 926,172
Loss before income taxes (1,455,186) (620,808)
Provision for income taxes
Net loss, including noncontrolling interest (1,455,186) (620,808)
Noncontrolling interest 3,213 4,350
Net loss attributable to FOXO (1,451,973) (616,458)
Deemed dividends from the issuances of preferred stock and triggers of down round provisions of Assumed Warrants (172,125)
Net loss to common stockholders (1,451,973) (788,583)
Preferred stock dividends – undeclared (284,772) (314,909)
Net loss to common stockholders, net of preferred stock dividends – undeclared $ (1,736,745) $ (1,103,492)
Common Class A [Member]    
Operating expenses:    
Net loss per share of Class A common stock, basic $ (0.00) $ (0.73)
Net loss per share of Class A common stock, diluted $ (0.00) $ (0.73)
Weighted average shares of Class A common stock, basic 3,112,449,040 1,506,959
Weighted average shares of Class A common stock, diluted 3,112,449,040 1,506,959